Anlon Healthcare Limited (AHCL) fundamentals
Anlon Healthcare Limited is a listed company in Pharmaceuticals & Biotechnology, part of the Healthcare sector, listed on the NSE as AHCL (ISIN INE0Y8W01025). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
Valuation and market data
| Last close | ₹24.70 |
|---|---|
| Market capitalisation | ₹118 crore |
| Enterprise value | ₹105 crore |
| P/E (TTM) | 4.04 |
| Price to book | 0.46 |
| Price to sales (TTM) | 0.36 |
| Book value per share | ₹53.52 |
| Dividend yield | 0.00% |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Listed since | Wed Sep 03 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹172 crore | ₹43 crore | ₹29 crore | 6.11 |
| Mar 2025 | ₹120 crore | ₹27 crore | ₹21 crore | 6.37 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Sep 2026:
| Promoters | 52.7% |
|---|---|
| Foreign institutions (FII) | 1.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.3% |
| Retail and others | 46.0% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.